Novartis Keeps Grip On Eye Drug Patent In Fed. Circ.
The Federal Circuit on Wednesday affirmed the validity of a portion of Novartis AG's patent for popular eye allergy treatment Patanol, leaving intact a lower judge's ruling that barred Apotex Inc....To view the full article, register now.
Already a subscriber? Click here to view full article